Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 3/20 | 1.00 |
| ▸ | CHRM4 | P08173 | 3/20 | 1.00 |
| ▸ | CHRM5 | P08912 | 3/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 3/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 3/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 3/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 3/20 | 1.00 |
| ▸ | CHRM3 | P20309 | 3/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 3/20 | 1.00 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 1.00 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 1.00 |
| ▸ | NR4A2 | P43354 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | PRNP | P04156 | 2/20 | 1.00 |
| ▸ | MTOR | P42345 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | APP | P05067 | 1/20 | 1.00 |
| ▸ | NQO2 | P16083 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chloroquine SCHEMBL8933 | 1.00 | CHRM2 (1.00) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| (R)-Chloroquine SCHEMBL29429108 | 1.00 | CHRM2 (1.00) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| Chloroquine SCHEMBL29363614 | 1.00 | CHRM2 (1.00) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| Chloroquine SCHEMBL8474661 | 1.00 | CHRM2 (1.00) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| Chloroquine SCHEMBL8934 | 1.00 | CHRM2 (1.00) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| Chloroquine SCHEMBL23854336 | 0.99 | CHRM2 (0.98) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| Chloroquine SCHEMBL3302947 | 0.99 | CHRM2 (0.98) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| Chloroquine SCHEMBL5488804 | 0.99 | CHRM2 (0.98) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| Chloroquine SCHEMBL9862220 | 0.99 | CHRM2 (0.98) | CHRM2CHRM4CHRM5ADRA2ACHRM1 | |
| Chloroquine SCHEMBL22534361 | 0.99 | CHRM2 (0.98) | CHRM2CHRM4CHRM5ADRA2ACHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 817 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4347012-B1 | PHOTOTHERAPY TREATMENT DEVICE | LUCIBEL SA (FR) | 2026-05-06 | — | — | EP | claimed |
| EP-4633638-A1 | TREATMENT OF PSYCHOLOGICAL FACTORS AFFECTING OTHER MEDICAL CONDITIONS (PFAOMC) | Luminous Mind Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| CN-107846890-B | Herbicidal composition comprising cycloheptane and a specific phytoene desaturase inhibitor | 巴斯夫农业公司 | 2024-09-03 | — | — | CN | claimed |
| WO-2024138897-A1 | NANOBODY TARGETING BCMA, CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF | 河北森朗生物科技有限公司 | 2024-07-04 | — | — | WO | claimed |
| WO-2024130044-A1 | TREATMENT OF PSYCHOLOGICAL FACTORS AFFECTING OTHER MEDICAL CONDITIONS (PFAOMC) | LUMINOUS MIND INC. (US) | 2024-06-20 | — | — | WO | claimed |
| EP-3324931-B1 | IN SITU CROSS-LINKABLE POLYSACCHARIDE COMPOSITIONS AND USES THEREOF | MERZ PHARMA GMBH & CO KGAA (DE) | 2023-11-29 | — | — | EP | claimed |
| CN-113354581-B | Preparation method and application of chiral chloroquine and phosphate thereof | 华南理工大学 | 2023-06-20 | — | — | CN | claimed |
| WO-2023069981-A1 | USES OF TAXIFOLIN FOR RESPIRATORY HEALTH | PHYTO TECH CORP. (US) | 2023-04-27 | — | — | WO | claimed |
| US-20230119141-A1 | USES OF TAXIFOLIN FOR RESPIRATORY HEALTH | PHYTO TECH CORP. | 2023-04-20 | — | — | US | claimed |
| WO-2021231314-A1 | METHODS OF TREATING COVID-19 USING TETRACYCLINE COMPOUNDS | PARATEK PHARMACEUTICALS INC. (US) | 2021-11-18 | — | — | WO | claimed |
| EP-1448220-A2 | ANTIPHLOGISTIC AGENT AND THE USE THEREOF | Kosmas KG (DE) | 2004-08-25 | — | — | EP | claimed |
| WO-2003045416-A2 | ANTIPHLOGISTIC AGENT AND THE USE THEREOF | KOSMAS KG (DE) | 2003-06-05 | — | — | WO | claimed |
| WO-2003039552-A1 | COMBINATION OF PDE4 OR PDE3/4 INHIBITOR AND AN ANTI-RHEUMATIC DRUG | ALTANA PHARMA AG (DE) | 2003-05-15 | — | — | WO | claimed |
| CN-1062133-C | Medicine for treating hypertensional sickness | CHANG PEIRUN (CN) | 2001-02-21 | — | — | CN | claimed |
| CN-1060339-C | Antirheumatic capsule capable of controlling inflammation and skeleton deformation of rheumatoid disease | SHEN CHUNLOU (CN) | 2001-01-10 | — | — | CN | claimed |
| CN-1200269-A | Medicine for treating hypertensional sickness | CHANG PEIRUN (CN) | 1998-12-02 | — | — | CN | claimed |
| EP-0879605-A2 | GLYCOSYL PRODRUG CONJUGATE WITH ENHANCED TOLERANCE | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-11-25 | — | — | EP | claimed |
| CN-1174035-A | Antirheumatic capsule capable of controlling inflammation and skeleton deformation of rheumatoid disease | SHEN CHUNLOU (CN) | 1998-02-25 | — | — | CN | claimed |
| US-4753984-A | Water soluble macromolecular prodrugs, their preparation and their use as antitumor and antiparasite medicines | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1988-06-28 | — | — | US | claimed |
| EP-0137868-A1 | 1-Substituted imidazole-5-carboxylic-acid derivatives, their preparation and their use as biocides | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-04-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230119141-A1 | USES OF TAXIFOLIN FOR RESPIRATORY HEALTH | ACE2, MAVS, ACE | CHRM2 4376/4885CHRM4 4237/4885CHRM5 4385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.